Weiss Multi Strategy Advisers LLC Infla Rx N.V. Transaction History

Weiss Multi Strategy Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $30,600 - $516,100	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.34 - $35.0 $70,416 - $84,000	2,400 Added 31.58%	10,000 $343,000
Q2 2018 Aug 14, 2018	BUY	$27.33 - $41.46 $16,398 - $24,876	600 Added 8.57%	7,600 $245,000
Q1 2018 May 15, 2018	BUY	$20.21 - $32.0 $141,470 - $224,000	7,000 New	7,000 $202,000

13.2M

5.2K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $61M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.